AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

Nov 14, 2013

30071_dirs_2013-11-14_47a945e2-efbb-4983-8f30-d02afa9b4d06.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-11-11

Reporting Person: Douglas Robert Andrew (COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-11	ResMed Common Stock	F	4983	$50.74	Disposed	111047.807	Direct
2013-11-11	ResMed Common Stock	F	5339	$50.74	Disposed	105708.807	Direct
2013-11-11	ResMed Common Stock	F	4636	$50.74	Disposed	101072.807	Direct

Footnotes

F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 12/17/2009 and vesting 11/11/2013.

F2: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/11/2010 and vesting 11/11/2013.

F3: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/15/2012 and vesting 11/11/2013.